Travel ETFs Climb on Hopes of Merck’s Oral COVID-19 Drug

Travel stocks and sector-related exchange traded funds surged on Friday after Merck revealed promising results for its oral COVID-19 drug. Among the best performing non-leveraged ETFs of Friday, the U.S. Global Jets ETF (NYSEArca: JETS) advanced 5.6%, the AdvisorShares Hotel ETF (BEDZ) increased...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.